Impact of the ProbeFix on the Workflow of Pharmacological Stress Echocardiography Examinations
Study Details
Study Description
Brief Summary
Pharmacological stress-echocardiography examinations are routinely performed in daily clinical practice. Usually, the echo probe is manually placed on the patient's thorax by the physician. The ProbeFix is a novel device, enabling the fixation of the ultrasound probe on the patient's thorax. Therefore, there is no need to manually hold the probe. This may improve the standardization of the examination and my reduce its duration. The present trial will investigate, whether the utilization of the ProbeFix reduces the duration of stress-echocardiography examinations and improves standardization of image acquisition.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: ProbeFix arm The echocardiography probe is fixated on the patient's thorax using the ProbeFix |
Other: ProbeFix
ProbeFix vs. manual hold of the ultrasound probe during pharmacological stress-echocardiography examinations
|
Active Comparator: Controll arm The sonographer manually holds the probe on the patient's thorax |
Other: Manual hold
ProbeFix vs. manual hold of the ultrasound probe during pharmacological stress-echocardiography examinations
|
Outcome Measures
Primary Outcome Measures
- Duration of stress-echocardiography examination [During the examination]
Duration from start of dobutamine infusion to end of stage IV of dobutamine infusion
Secondary Outcome Measures
- Echocardiography axis deviation in 4 chamber view [During the examination]
In 3-dimensional 4-chamber view, the deviation of the axis as compared to baseline will be assessed
Other Outcome Measures
- Cost-effectiveness [During the examination]
Assessment of cost-effectiveness, comparing a potential benefit in exam duration with costs of the ProbeFix
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients undergoing clinically indicated pharmacological stress-echocardiography
-
Willingness to participate
Exclusion Criteria:
-
Pharmacological stress echocardiography indication other than evaluation of stress induced ischemia (e.g. Low-Flow-Low-Gradient aortic valve stenoseis)
-
poor image quality
-
Early termination of the stress-echocardiography examination for clinical reasons
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University Hospital Essen | Essen | NRW | Germany | 45147 |
Sponsors and Collaborators
- Amir Abbas Mahabadi
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 19-TEMP815870-BO